| J9271 | Injection, pembrolizumab, 1 mg | 13,400 | $40 | $576.2K |
| J0897 | Injection, denosumab, 1 mg | 13,260 | $20 | $238.7K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,230 | $40 | $113K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,070 | $90 | $92.2K |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 2,480 | $40 | $89.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 380 | $90 | $35.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 270 | $130 | $34.7K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 370 | $80 | $30.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 190 | $90 | $17.1K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 550 | $20 | $11.5K |